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Evaluation of a Chromogenic Agar under Development To
Screen for VRE Colonization䌤
George Kallstrom, Christopher D. Doern, and W. Michael Dunne, Jr.*
Department of Pathology and Immunology, Washington University, St. Louis, Missouri

BBL CHROMagar VanRE (CVRE) was compared with bile esculin azide agar plus vancomycin to screen for
vancomycin-resistant enterococcus (VRE) colonization. CVRE distinguishes Enterococcus faecalis (green colonies) from Enterococcus faecium (mauve colonies) on the basis of chromogenic substrate use. CVRE sensitivity
and specificity were 98.6% and 99.1%. Positive and negative predictive values were 95.9% and 99.7%.
positive colonies and another 24 to 48 h to confirm identification and vancomycin resistance (5). Several formulations of
media have been developed in recent years that reduce the
turnaround time for VRE screening. Many of these media
contain chromogenic substrates that allow visual confirmation
of positive colonies, thereby reducing or eliminating the need
for extensive secondary testing (1). NAAT is more rapid, but
increased cost and complexity make this type of testing more
burdensome than agar plate screening.
For this study, 400 remnant deidentified consecutive nonduplicated stool specimens were simultaneously cultured on
CHROMagar VanRE (CVRE) and BEAV and evaluated for
the presence of VRE after 24 and 48 h of incubation at 35 to
37°C in a 5% CO2-enriched atmosphere and ambient air, respectively. Colonies recovered on BEAV were presumptively
identified as VRE by the results of testing that included Gram
stain morphology analysis, a negative catalase reaction, and
PYR (L-pyrrolidonyl-␤-naphthylamide) hydrolysis. Isolates
were subcultured for phenotypic identification (VITEK2, bioMérieux, Durham, NC) and vancomycin susceptibility testing
by broth microdilution. Similarly, colonies producing a characteristic green or mauve color on CVRE (Fig. 1) were

Vancomycin-resistant enterococci (VRE) commonly colonize the gastrointestinal tract of humans and can cause outbreaks of increased colonization rates and occasional extraintestinal infections, including bacteremia and peritonitis in
pediatric, elderly, or immunocompromised patients (2). Liver
transplant patients and patients with hematologic malignancies
are at particular risk for severe disease (3, 6, 7). The prevalence
of VRE colonization increases with age and exposure to antibiotics (2). Treatment regimens that include exposure of patients
to cephalosporins or glycopeptides that eradicate normal bowel
flora often allow VRE to proliferate. Although the practice is
controversial (4), many hospitals as a part of their infection prevention measures currently screen at-risk patients for VRE colonization. Contact precautions are typically implemented for
VRE-colonized patients to control nosocomial spread of VRE
among noncolonized or other high-risk patients.
Screening methods for VRE detection rely on either a culture-based method, generally consisting of an agar medium
containing 4 to 8 g of vancomycin and bile esculin (BEAV) to
detect bile esculin-positive vancomycin-resistant organisms, or
nucleic acid amplification testing (NAAT). Culture-based
screening methods using BEAV require 24 to 48 h to identify

FIG. 1. Growth of E. faecium (A), E. faecalis (B), and mixed E. faecalis and E. faecium (C) on BBL CHROMagar VanRE.
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TABLE 1. VRE testing resultsa
No. of isolates with indicated result

Incubation duration
(h) and test category

Species
TP

TN

FP

FN

n

%
Sensitivity

%
Specificity

PPV
(%)

NPV
(%)

24
VREfm
VREfs
VREfm and VREfss

107
16
123

273
379
652

3
3
6

17
2
19

400
400
800

86.3
88.9
86.6

98.9
99.2
99.1

97.3
84.2
95.3

94.1
99.5
97.2

CVRE ⫹ catalase,
Gram stain

VREfm
VREfs
VREfm and VREfs

107
16
123

274
379
653

2
3
5

17
2
19

400
400
800

86.3
88.9
86.6

99.3
99.2
99.2

98.2
84.2
96.1

94.2
99.5
97.2

CVRE alone

VREfm
VREfs
VREfm and VREfs

123
17
140

272
373
651

4
10
7

1
0
2

400
400
800

99.2
100.0
98.6

98.6
97.4
98.9

96.9
63.0
95.2

99.6
100.0
99.7

CVRE ⫹ catalase,
Gram stain

VREfm
VREfs
VREfm and VREfs

123
17
140

274
378
652

2
5
6

1
0
2

400
400
800

99.2
100.0
98.6

99.3
98.7
99.1

98.4
77.3
95.9

99.6
100.0
99.7

48

a
TP (true positive), mauve or green colonies on CVRE, black on BEAV, confirmed by Vitek and MIC testing to represent VRE; TN (true negative), no mauve or
green colonies on CVRE, no VRE from BEAV; FP (false positive), mauve or green colonies on CVRE, no VRE isolated on BEAV; FN (false negative), no mauve
or green colonies on CVRE, VRE isolated on BEAV. “CVRE alone” data do not include catalase and Gram stain results. “CVRE ⫹ catalase ⫹ Gram stain” data
include CVRE results along with catalase and Gram stain results.

subcultured for identification and microbroth susceptibility
testing. Sensitivity, specificity, positive predictive values
(PPV), and negative predictive values (NPV) were calculated and are presented in Table 1. Quality control testing
was performed daily and included both vancomycin-sensitive and vancomycin-resistant Enterococcus spp.
One hundred and twenty-four VRE E. faecium (VREfm) and
18 VRE E. faecalis (VREfs)-positive specimens were recovered
from the traditional media. With no additional testing, CVRE
provided a sensitivity and specificity of 86.3% and 98.9% for the
detection of VREfm and 88.9% and 99.2% for the detection of
VREfs when read after 24 h of incubation. If the incubation was
extended to 48 h, the sensitivity and specificity of the medium
were 99.2% and 98.6% for VREfm and 100% and 97.4% for
VREfs. Performing catalase and Gram stain testing of presumptively positive isolates increased the specificity slightly for both E.
faecium and E. faecalis. The prevalence of VREfm colonization at
our institution was 31%, while VREfs was present in 4.5% of the
specimens tested. PPV and NPV values for each are shown in
Table 1. The cumulative PPV values for all VRE were 96.1% (24
h) and 95.9% (48 h). Cumulative NPV for all VRE were 97.2%
(24 h) and 99.7% (48 h).
False-positive results for VREfs (green colonies) were
predominantly caused by yeast colonies (5 of 10 false-positive colonies), which came up slowly and turned the medium
green by 48 h of incubation and led to a fairly low positive
predictive value for VREfs at 48 h. However, when Gram
stain and catalase testing were included in the analysis, the
PPV improved from 63.0% to 77.3%. Three additional falsepositive results for VREfs were found for single isolates of
E. casseliflavus, Streptococcus mutans, and E. raffinosis. Simple additional testing could have eliminated all of these
false-positive results (a motility test for E. casseliflavus, PYR
testing for S. mutans, and raffinose utilization for E. raffinosis). There were one E. faecium isolate and one E. faecalis

isolate that produced green colonies on CVRE and not
found on BEAV. The false-positive Enterococcus spp. were
confirmed to be VRE but were not isolated from BEAV, so
they were counted as false positives in the analysis. There
were four “false-positive” VREfm (mauve colony) isolates,
namely, one Staphylococcus sciuri isolate, one Gram-negative rod isolate, and two VREfm isolates not identified on
BEAV. Of these, Gram staining would have eliminated the
Gram-negative rod isolate and a positive catalase test result
would have eliminated the S. sciuri isolate. Performing
Gram stain and catalase testing alone increased the PPV for
VREfm from 96.9% to 98.4%.
We conclude that CVRE is a rapid, sensitive, and specific
medium for the detection of VRE from stool specimens at
24 h. A further gain in sensitivity can be attained by holding the
plates for a 48-h evaluation. Performing rapid catalase and
Gram stain testing increases the specificity of the medium.
Screening for VRE by the use of CVRE medium is more rapid
than traditional screening. This medium performs as well as
the gold standard BEAV medium and caneliminate the need
for extensive biochemical identification and antibiotic susceptibility testing.
This study was funded by Becton Dickinson, Baltimore, MD.
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